Fulgent Genetics (FLGT) Net Cash Flow (QoQ) (2016 - 2026)
Fulgent Genetics (FLGT) Net Cash Flow (QoQ) (2016 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Fulgent Genetics | 515.29 Mn | 258.26 Mn | 25.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 110.52% |
| Mar 31, 2026 | 60.31% |
| Dec 31, 2025 | -327.00% |
| Sep 30, 2025 | 44.43% |
| Jun 30, 2025 | 69.84% |
| Mar 31, 2025 | 538.71% |
| Dec 31, 2024 | 61.02% |
| Sep 30, 2024 | -167.90% |
| Jun 30, 2024 | 124.44% |
| Mar 31, 2024 | -422.42% |
| Dec 31, 2023 | -48.72% |
| Sep 30, 2023 | 439.25% |
| Jun 30, 2023 | 42.99% |
| Mar 31, 2023 | 84.98% |
| Dec 31, 2022 | -400.59% |
| Sep 30, 2022 | 113.85% |
| Jun 30, 2022 | -213.58% |
| Mar 31, 2022 | 476.19% |
| Dec 31, 2021 | -143.72% |
| Sep 30, 2021 | 324.35% |